Phage Display Assay for Microbial Redox Enzyme Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensors face limitations in detecting a wide range of analytes in real-time due to the lack of efficient methods for identifying and utilizing microbial redox enzymes, which are essential for accurate and sensitive measurements in environmental, industrial, and clinical settings.
Innovation Solution
A high-throughput assay and system for identifying microbial redox enzymes (MREs) from environmental sources, utilizing a functional MRE assay that produces a detectable signal, such as fluorescence, in the presence of hydrogen peroxide, allowing for the identification and isolation of oxidases and other redox enzymes for use in biosensors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional antibody-based biosensing is used, then molecular specificity is achieved, but development cost and time increase significantly
Solution Approach 1:
The patent uses phage display technology to generate libraries of antibody fragments (scFv, Fab) that can be screened and selected in vitro without requiring animal immunization. These engineered antibody fragments serve as disposable, cost-effective recognition elements that eliminate the need for traditional long-term animal studies while maintaining molecular specificity.
Solution Approach 2:
The patent replaces the biological mechanical system of animal immunization and monoclonal isolation with an in vitro phage display system. This substitution allows for rapid generation and screening of antibody variants using molecular biology techniques, dramatically reducing development time from months/years to weeks while maintaining specificity.
2Reliability
If recombinant antibody production techniques are used, then reproducibility improves, but production cost increases due to mammalian cell lines
Solution Approach 1:
The patent employs phage display technology to generate and screen antibody fragments in vitro, eliminating the need for expensive mammalian cell lines. The selected antibody sequences can then be produced in bacterial systems, which are significantly cheaper while maintaining reproducibility through standardized molecular biology protocols.
Solution Approach 2:
The patent changes the production system parameters from mammalian cell lines to bacterial expression systems. This parameter change reduces production costs while maintaining reproducibility through the use of well-characterized bacterial hosts and standardized expression vectors, making antibody production more accessible and scalable.
3Measurement precision
If aptamers are used as recognition elements, then recognition of small molecules improves, but identification of aptamer sequences becomes technically challenging
Solution Approach 1:
The patent replaces the complex SELEX process for aptamer identification with phage display technology. This substitution simplifies the identification process by using combinatorial libraries of antibody fragments that can be screened directly against target molecules, reducing technical complexity while maintaining or improving recognition capability for small molecules.
4Measurement precision
If both antibodies and aptamers are used as biorecognition elements, then specific binding is achieved, but inherent transduction mechanism is lacking
Solution Approach 1:
The patent merges the specific binding capability of antibodies with electrochemical transduction by immobilizing the selected antibody fragments directly onto electrochemical sensors. This combination creates integrated biosensors where the antibody provides specificity and the electrochemical interface provides direct signal transduction, eliminating the need for separate transduction mechanisms and reducing overall device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the development of sensitive and reliable biosensors capable of detecting a virtually unlimited number of analytes, overcoming the limitations of existing technologies by providing a rapid and efficient method for identifying and utilizing MREs, thereby enhancing analytical capabilities in various applications.
Implementation Method 1
If the analyte is catalyzed by a microbial redox enzyme (MRE), then the target analyte will be oxidized or reduced to generate a product and also can produce a redox mediator (Med)
Implementation Method 2
the redox mediator (Med) that transfers electrons from the Med to readout substrate (ReadS) to generate a readout product (ReadP) produces a detectable signal
Implementation Method 3
utilizing a functional MRE assay that produces a detectable signal, such as fluorescence, in the presence of hydrogen peroxide
Data Source
AI summary
Described herein are systems, assays, methods and compositions for identification of oxidase microbial redox-enzymes (MREs) specific to an analyte of interest from an environmental source. The technology relates to identification of analyte-responsive MREs that can quantify the concentration of a target analyte with high specificity and high sensitivity, for example, where the identified analyte-responsive redox-enzyme can be used to engineer an electrochemical biosensor.